PHR Phreesia, Inc.
Services-Business Services, NEC · NYSE · SEC CIK 1412408 · Fiscal year ends 01/31
Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY12.9%
TTM net income YoY143.4%
TTM EPS YoY142.9%
Revenue 3-yr CAGR16.7%
Net income 3-yr CAGR—
Margins
Gross margin85.4%
Operating margin2.5%
Net margin2.1%
FCF margin15.9%
EBITDA margin9.8%
Returns
ROE3.1%
ROA2.0%
ROIC (approx.)4.4%
Asset turnover0.96x
Leverage & solvency
Liabilities / assets42.5%
Debt / equity0.18x
Current ratio1.76x
Interest coverage1.23x
Cash quality & payout
Operating cash flow / net income8.75x
Accruals ratio-15.3%
Payout ratio—
Capex / revenue2.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-01-31 | FY20252025-01-31 | FY20242024-01-31 | FY20232023-01-31 | FY20222022-01-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $480.59M | $419.81M | $356.30M | $280.91M | $213.23M |
| Cost of revenue | $71.36M | $66.23M | $61.02M | $58.94M | $42.67M |
| Gross profit | $409.23M | $353.59M | $295.27M | $221.97M | $170.56M |
| R&D expense | $121.48M | $117.36M | $112.35M | $91.24M | $52.27M |
| SG&A expense | $79.90M | $76.60M | $79.93M | $80.38M | $68.67M |
| Operating income | -$6.61M | -$58.10M | -$136.48M | -$176.55M | -$116.82M |
| Interest expense | $6.95M | $2.35M | $1.85M | $1.41M | $1.16M |
| Pretax income | -$8.94M | -$55.81M | -$135.34M | -$175.66M | -$117.98M |
| Income tax | -$11.25M | $2.72M | $1.54M | $483,000 | $182,000 |
| Net income | $2.31M | -$58.53M | -$136.88M | -$176.15M | -$118.16M |
| EBITDA | $24.84M | -$30.21M | -$106.99M | -$151.25M | -$95.52M |
| EPS (basic) | 0.04 | -1.02 | -2.51 | -3.36 | -2.37 |
| EPS (diluted) | 0.04 | -1.02 | -2.51 | -3.36 | -2.37 |
| Weighted avg. shares (diluted) | 61.49M | 57.59M | 54.56M | 52.44M | 49.89M |
| Banking | |||||
| Net interest income | — | — | $2.21M | $1.06M | -$1.08M |
| Balance sheet | |||||
| Cash & equivalents | $73.83M | $84.22M | $87.52M | $176.68M | $313.81M |
| Receivables | $97.45M | $73.62M | $64.86M | $51.39M | $40.26M |
| Current assets | $279.84M | $203.28M | $195.68M | $262.44M | $386.35M |
| PP&E, net | $20.33M | $23.65M | $16.90M | $21.67M | $34.65M |
| Goodwill | $170.06M | $75.84M | $75.84M | $33.74M | $33.62M |
| Intangibles | $79.76M | $28.14M | $31.62M | $11.40M | $12.77M |
| Total assets | $663.79M | $388.42M | $370.33M | $370.06M | $494.48M |
| Current liabilities | $183.24M | $114.02M | $110.12M | $79.04M | $68.43M |
| Short-term debt | $7.97M | $8.04M | $6.06M | $5.17M | $5.82M |
| Long-term debt | $92.12M | $8.15M | $5.40M | $2.73M | $7.42M |
| Total debt | $100.09M | $16.19M | $11.46M | $7.90M | $13.24M |
| Total liabilities | $326.58M | $123.61M | $118.88M | $82.24M | $77.20M |
| Shareholders' equity | $337.21M | $264.81M | $251.45M | $287.82M | $417.28M |
| Net debt | $26.26M | -$68.03M | -$76.06M | -$168.79M | -$300.57M |
| Cash flow statement | |||||
| Operating cash flow | $78.81M | $32.38M | -$32.38M | -$90.12M | -$74.71M |
| Capital expenditure | $11.10M | $8.71M | $5.81M | $4.73M | $18.42M |
| Free cash flow | $67.71M | $23.67M | -$38.18M | -$94.86M | -$93.13M |
| Investing cash flow | -$161.88M | -$24.09M | -$39.67M | -$26.20M | -$65.23M |
| Financing cash flow | $72.85M | -$11.49M | -$17.11M | -$20.80M | $234.97M |
| Depreciation & amortization | $31.45M | $27.89M | $29.49M | $25.30M | $21.30M |
| Stock-based compensation | $67.45M | $66.97M | $71.61M | $58.77M | $36.14M |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.